Amyloïd-PET bij patiënten met de ziekte van Alzheimer

Until a few years ago, amyloid plaques in the brains of patients with Alzheimer’s disease could only be demonstrated by means of neuropathological examination. New PET tracers allow for visualisation of these amyloid plaques in living patients. Biological validity and clinical relevance of this technique have been established. Expertise in interpretation of the images and the diagnostic impact is required. Cost effectiveness and added value over existing methods in terms of diagnosis and prognosis are still being investigated.

Conflict of interest and financial support: ICMJE forms provided by the authors are available online along with the full text of this article.